CHPA advocates for significant increases in the U.S. Food and Drug Administration (FDA) funding so that it can
maintain its myriad of responsibilities, including timely reviews of new
over-the-counter (OTC) medicines.
FDA has jurisdiction over $1 for every $5 spent in the U.S. with products ranging from food and drugs to medical devices and cosmetics. FDA has been underfunded for a number of years and the challenges presented by lack of funding make it more difficult for the agency to fulfill its core mission of ensuring the safety of the nation’s food and drug supply and ensuring timely approvals of innovative medical products that benefit consumers.
As a founding member of the Alliance for a Stronger FDA, CHPA advocates for significant increases in FDA funding so that it can maintain its myriad of responsibilities, including timely reviews of new OTC medicines. This coalition has now grown to more than 180 members supporting an increase in resources to FDA.